New research suggests LVADs may not solve mitral regurgitation for some patients with poor right heart function.

A team of researchers are looking at all angles to figure out how to reduce the rates of health-care-associated infections for patients who get ventricular assist devices.

Recent approval from the FDA for HeartMate 3 opens the door to an important option for people with advanced heart failure.